Related Experiment Video
Updated: Aug 9, 2026
Real-time Cytotoxicity Assays in Human Whole Blood
Published on: November 7, 2014
Natural cytotoxicity of mouse, rat, and human lymphocytes against heterologous target cells
Abstract:
Natural cell-mediated cytotoxicity by a particular subpopulation of lymphocytes [designated natural killer (NK) cells] in NIH Swiss nude and CBA/N mice, WF rats, and humans was demonstrated against tumor cells in 4-hour 51Cr release assays. In most studies, only reactivity against target cells of the homologous species was examined. In the present studies, mouse NK activity also was found against a rat lymphoma tissue culture cell line and against human tissue culture lines. Rat NK cells reacted not only against syngeneic tumor cells but also against heterologous tumor cell lines. In contrast to the heterologous NK activity in rodents, no significant NK activity of human peripheral blood lymphocytes against heterologous targets was found in the present studies. In mice and rats the effector cells that mediated the cytotoxicity against heterologous target cells were indistinguishable from NK cells, the effector cells being nonadherent and nonphagocytic. In addition, the mouse effector cells for heterologous activity as well as mouse NK cells were sensitive to repeated treatment with anti-Thy 1.2 serum plus complement. The specificities of these reactions were indicated by a cold target inhibition assay. The results indicated a sharing of specificities between homologous and heterologous tumor cells recognized by mouse and rat NK cells. In contrast, only the human cell lines were able to appreciably inhibit the cytotoxicity of human peripheral blood lymphocytes.
Insights
Natural killer (NK) cells in mice and rats can target tumor cells from different species, unlike human NK cells. This cross-species reactivity highlights shared specificities in tumor cell recognition by rodent NK cells.
Area of Science:
- Immunology
- Cell Biology
Background:
- Natural killer (NK) cells are lymphocytes mediating innate immune responses against tumor cells.
- Previous studies primarily focused on homologous (within-species) NK cell activity.
- The cross-reactivity of NK cells against heterologous (across-species) targets remains less understood.
Purpose of the Study:
- To investigate the cross-species reactivity of natural killer (NK) cells from mice, rats, and humans against tumor cell lines.
- To characterize the effector cells responsible for heterologous NK activity and compare them to homologous NK cells.
- To determine if specificities are shared between homologous and heterologous tumor cells recognized by NK cells.
Main Methods:
- Utilized 51Cr release assays to measure natural cell-mediated cytotoxicity.
- Tested NK cell activity from mice, rats, and humans against homologous and heterologous tumor cell lines.
- Characterized effector cells by assessing adherence, phagocytosis, and sensitivity to anti-Thy 1.2 serum plus complement.
- Employed cold target inhibition assays to analyze reaction specificities.
Main Results:
- Mouse NK cells exhibited cytotoxicity against rat and human tumor cell lines.
- Rat NK cells demonstrated reactivity against both syngeneic and heterologous tumor cells.
- Human peripheral blood lymphocytes showed significant NK activity only against human target cells.
- Effector cells mediating heterologous NK activity in rodents were indistinguishable from NK cells and sensitive to anti-Thy 1.2 treatment.
- Evidence of shared specificities between homologous and heterologous tumor cells recognized by mouse and rat NK cells was observed.
Conclusions:
- Rodent NK cells possess broader cross-species reactivity compared to human NK cells.
- This cross-reactivity suggests shared molecular targets or recognition mechanisms on tumor cells.
- The findings contribute to understanding the evolutionary and functional diversity of NK cell-mediated immunity.
